Aspirin and spinal haematoma after neuraxial anaesthesia: Myth or reality?

British Journal of Anaesthesia

Volumn 115, Issue 5, 2015, Pages 688-698

  Vela Vasquez R S ^a   Pelaez Romero R ^a  

^a HOSPITAL SON LLÀTZER   (Spain)

Author keywords

anesthesia, epidural; anesthesia, spinal; aspirin; platelet aggregation inhibitors; spinal haematoma

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; AUSTRIA; BELGIUM; CLINICAL PRACTICE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EUROPEAN UNION; EVIDENCE BASED PRACTICE; GERMANY; HUMAN; ITALY; LOW DRUG DOSE; MEDICAL SOCIETY; NERVE BLOCK; NEURAXIAL ANAESTHESIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SCANDINAVIA; SPAIN; SPINAL HEMATOMA; UNITED KINGDOM; UNITED STATES; ADVERSE EFFECTS; DOSE RESPONSE; EPIDURAL ANESTHESIA; EVIDENCE BASED MEDICINE; HEMATOMA, EPIDURAL, SPINAL; OPERATIVE BLOOD LOSS; PROCEDURES; SPINAL ANESTHESIA;

ANESTHESIA, EPIDURAL; ANESTHESIA, SPINAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BLOOD LOSS, SURGICAL; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HEMATOMA, EPIDURAL, SPINAL; HUMANS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC;

EID: 84946138545     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aev348     Document Type: Review

References (138)

1. Tryba M. Epidural regional anesthesia and low molecular heparin: Pro. Anasthesiol Intensivmed Notfallmed Schmerzther. 1993; 28: 179-81
2. Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg. 1994; 79: 1165-77
3. Stafford-Smith M. Impaired haemostasis and regional anesthesia. Can J Anaesth. 1996; 43: R129-41
4. Horlocker TT, Wedel DJ. Neuraxial block and low-molecularweight heparin: balancing perioperative analgesia and thromboprophylaxis. Reg Anesth Pain Med. 1998; 23: 164-77
5. Schroeder DR. Statistics: detecting a rare adverse drug reaction using spontaneous reports. Reg Anesth Pain Med. 1998; 23: 183-9
6. Cameron CM, Scott DA, McDonald WM, Davies MJ A review of neuraxial epidural morbidity: experience of more than 8, 000 cases at a single teaching hospital. Anesthesiology. 2007; 106: 997-1002
7. Pöpping DM, Zahn PK, Van Aken HK, Dasch B, Boche R, Pogatzki-Zahn E. Effectiveness and safety of postoperative pain management: a survey of 18 925 consecutive patients between 1998 and 2006 (2nd revision): a database analysis of prospectively raised data. Br J Anaesth. 2008; 101: 832-40
8. Cook TM, Counsell D, Wildsmith JAW. Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists. Br J Anaesth. 2009; 102: 179-90
9. Horlocker TT. Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy. Br J Anaesth. 2011; 107(Suppl 1): i96-i106
10. Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology. 2004; 101: 950-9
11. Li S, Wang D, Ma D. Epidural hematoma after neuraxial blockade: a retrospective report from China. Anesth Analg. 2010; 111: 1322-4
12. Pumberger M, Memtsoudis SG, Stundner O, Herzog R, Boettner F, Gausden E, et al. An analysis of the safety of epidural and spinal neuraxial anesthesia in more than 100, 000 consecutive major lower extremity joint replacements. Regional Anesth Pain Med. 2013; 38: 515-9
13. Vandvik PO, Lincoff AM, Gore JM, Gutterman DD, Sonnenberg FA, Alonso-Coello P, et al. Primary and Secondary Prevention of Cardiovascular Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141: e637S-68S
14. Alonso-Coello P, Bellmunt S, McGorrian C, Anand SS, Guzman R, Criqui MH, et al. Antithrombotic Therapy in Peripheral Artery Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141: e669S-90S
15. Halvorsen S, Andreotti F, ten Berg JM, Cattaneo M, Coccheri S, Marchioli R, et al. Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis. J Am Coll Cardiol. 2014; 64: 319-27
16. Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Circulation. 2010; 121: 2694-701
17. Patrono C, Bachmann F, Baigent C, Bode C, De Caterina R, Charbonnier B, et al. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J. 2004; 25: 166-81
18. Sierra P, Castillo J, Sabaté S, Estanyol N, Paniagua P. Continuous perioperative aspirin has not been associated with postoperative adverse events in noncardiac surgery. Eur J Anaesthesiol. 2009; 26(Suppl 45): 4
19. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008; 371: 1839-47
20. Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014; 370: 1494-503
21. Llau JV, de Andrés J, Gomar C, GómezA, Hidalgo F, Sahagún J, et al. Drugs that alter hemostasis and regional anesthetic techniques: safety guidelines. Consensus conference. Rev Esp Anestesiol Reanim. 2001; 48: 270-8
22. GogartenW, Van Aken H, Büttner J, Riess H, Wulf H, Bürkle H. Rückenmarksnahe Regionalanästhesien und Thromboembolieprophylaxe/.antithrombotische Medikation. Überarbeitete Leitlinien der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin. Anaesth Intensivmed. 2003; 44: 218-230
23. Kozek-Langenecker SA, Fries D, Gutl M, Hofmann N, Innerhofer P, Kneifl W, et al. Locoregional anesthesia and coagulation inhibitors. Recommendations of the Task Force on Perioperative Coagulation of the Austrian Society for Anesthesiology and Intensive Care Medicine. Anaesthesist. 2005; 54: 476-84
24. Bertini L, Savoia G, De Nicola A, Ivani G, Gravino E, Albani A, et al. SIAARTI guidelines for safety in locoregional anaesthesia. Minerva Anestesiol. 2006; 72: 689-722
25. Gogarten W, Van Aken H, Büttner H, Riess H, Wulf H, Bürkle H. Regional anesthesia and thromboembolism prophylaxis/anticoagulation - Revised recommendations of the German Society of Anaesthesiology and Intensive Care Medicine. Anästh Intensivmed. 2007; 48: S109-S124
26. GogartenW, Vandermeulen E, Van Aken H, Kozek S, Llau JV, Samama CM. Regional anesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol. 2010; 27: 999-1015
27. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med. 2010; 35: 64-101
28. Breivik H, Bang U, Jalonen J, Vigfússon G, Alahuhta S, Lagerkranser M. Nordic guidelines for neuraxial blocks in disturbed haemostasis from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. Acta Anaesthesiol Scand. 2010; 54: 16-41
29. Sierra P, Gómez-Luque A, Castillo J, Llau JV. Clinical practice guidelines for the perioperative management of antiplatelet therapy in noncardiac surgery (Sociedad Española de Anestesiología y Reanimación). Rev Esp Anestesiol Reanim. 2011; 58 (Suppl 1): 1-16
30. Vandermeulen E, Decoster J, Dewandre PY, Ickx BE, Vercauteren M, Verhamme P. Central neural blockade in patients with a drug-induced alteration of coagulation. Third edition of the Belgian Association for Regional Anaesthesia (BARA) Guidelines. Acta Anaesthesiol Belg. 2011; 62: 175-91
31. Association of Anaesthetists of Great Britain & Ireland, Obstetric Anaesthetists Association, Regional Anaesthesia UK. Regional anesthesia and patients with abnormalities of coagulation: the Association of Anaesthetists of Great Britain & Ireland The Obstetric Anaesthetists Association Regional Anaesthesia UK. Anaesthesia. 2013; 68: 966-72
32. www.oegari.at. Regionalanästhesie unter gerinnungshemmender Medikation. Empfehlungen der Arbeitsgruppe perioperative Gerinnung der ÖGARI. Update june 2013. Available in: http://www.oegari.at/web-files/dateiarchiv/.editor/regionalanaesthesie-und-gerinnungshemmer-2013-1.pdf
33. BurgerW, Chemnitius J, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-Analysis. J Intern Med. 2005; 257: 399-414
34. Biondi-Zoccai G, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, et al A systematic review and metaanalysis on the hazards of discontinuing or not adhering to aspirin among 50, 279 patients at risk for coronary artery disease. Eur Heart J. 2006; 27: 2667-74
35. Servin F. Low-dose aspirin and clopidogrel: how to act in patients scheduled for day surgery. Curr Opin Anesthesiol. 2007; 20: 531-4
36. Chassot P, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth. 2007; 99: 316-28
37. Oscarsson A, Gupta A, Fredrikson M, Järhult J, Nyström M, Pettersson E, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth. 2010; 104: 305-12
38. Guay J, Choi PT, Suresh S, Albert N, Kopp S, Pace NL. Neuraxial anesthesia for the prevention of postoperative mortality and major morbidity: an overview of Cochrane systematic reviews. Anesth Analg. 2014; 119: 716-725
39. Moraca RJ, Sheldon DG, Thirlby RC. The role of epidural anesthesia and analgesia in surgical practice. Ann Surg. 2003; 238: 663-73
40. Patrono C, Baigent C, Hirsh J, Roth G. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical PracticeGuidelines (8th Edition). Chest. 2008; 133: 199S-233S
41. Patrono C, Andreotti F, Arnesen H, Badimon L, Baigent C, Collet J, et al. Antiplatelet agents for the treatment and prevention of atherothrombosis. Eur Heart J. 2011; 32: 2922-32
42. Hall R, Mazer CD. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesth Analg. 2011; 112: 292-318
43. Arzamendi D, Freixa X, Puig M, Heras M. Mecanismos de acción de los fármacos antitrombóticos. Rev Esp Cardiol. 2006; 6: 2H-10H
44. Awtry EH, Loscalzo J. Aspirin. Circulation. 2000; 101: 1206-1218
45. van Pampus EC, Huijgens PC, Zevenbergen A, Twaalfhoven H, van KampGJ, Langenhuijsen MM. Influence of aspirin on human megakaryocyte prostaglandin synthesis. Eur J Haematol. 1993; 50: 264-268
46. Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest. 1982; 69: 1366-72
47. Patrono C, Ciabattoni G, Patrignani P, Pugliese F, Filabozzi P, Catella F, et al. Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation. 1985; 72: 1177-84
48. Bochner F, Lloyd JV. Aspirin for myocardial infarction. Clinical pharmacokinetic considerations. Clin Pharmacokinet. 1995; 28: 433-8
49. Santilli F, Rocca B, De Cristofaro R, Lattanzio S, Pietrangelo L, Habib A, et al. Platelet cyclooxygenase inhibition by lowdose aspirin is not reflected consistently by platelet function assays: implications for aspirin resistance . J Am Coll Cardiol. 2009; 53: 667-77
50. FitzGerald GA, Oates JA, Hawiger J, Maas RL, Roberts LJ, Lawson JA, et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest. 1983; 71: 676-88
51. Reilly IAG, FitzGerald GA. Inhibition of thromboxane formation in vivo and ex vivo: Implications for therapy with platelet inhibitory drugs. Blood. 1987; 69: 180-6
52. Sonksen JR, Kong KL, Holder R. Magnitude and time course of impaired primary haemostasis after stopping chronic low and medium dose aspirin in healthy volunteers. Br J Anaesth. 1999; 82: 360-5
53. Coleman JL, Alberts MJ. Effect of aspirin dose, preparation, and withdrawal on platelet response in normal volunteers. Am J Cardiol. 2006; 98: 838-41
54. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007; 115: 1634-42
55. Chronos NA, Wilson DJ, Janes SL, Hutton RA, Buller NP, Goodall AH. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alphagranules or lysosomes from, human platelets. Clin Sci. 1994; 87: 575-80
56. Packham MA. Role of platelets in thrombosis and hemostasis. Can J Physiol Pharmacol. 1994; 72: 278-84
57. Steinhubl SR, Moliterno DJ. The role of the platelet in the pathogenesis of atherothrombosis. Am J Cardiovasc Drugs. 2005; 5: 399-408
58. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res. 2006; 99: 1293-304
59. Meadows TA, Bhatt DL. Clinical aspects of platelet inhibitors and thrombus formation. Circ Res. 2007; 100: 1261-75
60. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141: e326S-50S
61. Patrono C, García Rodríguez L, Landolfi R, Baigent C. Lowdose aspirin for the prevention of atherothrombosis. N Engl J Med. 2005; 353: 2373-83
62. McQuaid KR, Laine L. Systematic review and meta-Analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med. 2006; 119: 624-38
63. Patrono C. Low-dose aspirin in primary prevention: cardioprotection, chemoprevention, both, or neither? Eur Heart J. 2013; 34: 3403-11
64. Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, et al. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med. 2012; 367: 1979-87
65. Berger JS, Brown DL, Becker RC. Low-dose aspirin in patients with stable cardiovascular disease: a meta-Analysis. Am J Med. 2008; 121: 43-9
66. Antithrombotic Trialists Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J. 2002; 324: 71-86
67. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem. 1996; 271: 33157-60
68. Kearney P, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-Analysis of randomised trials. Br Med J. 2006; 332: 1302-1308
69. Zarraga IGE, Schwarz ER. Coxibs and heart disease: what we have learned and what else we need to know. J Am Coll Cardiol. 2007; 49: 1-14
70. Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature. 1997; 388: 678-82
71. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science. 2002; 296: 539-41
72. UK-TIA Study Group. The United Kingdom Transient Ischemic Attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatr. 1991; 54: 1044-54
73. Dutch TIA Trial Study Group A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med. 1991; 325: 1261-6
74. Taylor DW, Barnett HJ, Haynes RB, Ferguson GG, Sackett DL, Thorpe KE, et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet. 1999; 353: 2179-84
75. He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-Analysis of randomized controlled trials. JAMA. 1998; 280: 1930-5
76. Roderick PJ, Wilkes HC, Meade TW. The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol. 1993; 35: 219-26
77. McKenna R, Galante J, Bachmann F, Wallace DL, Kaushal PS, Meredith P. Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med J. 1980; 280: 514-7
78. Harris WH, Athanasoulis CA, Waltman AC, Salzman EW. High and low-dose aspirin prophylaxis against venous thromboembolic disease in total hip replacement. J Bone Joint Surg Am. 1982; 64: 63-6
79. Harris WH, Athanasoulis CA, Waltman AC, Salzman EW. Prophylaxis of deep-vein thrombosis after total hip replacement. Dextran and external pneumatic compression compared with 1.2 or 0.3 gram of aspirin daily. J Bone Joint Surg Am. 1985; 67: 57-62
80. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Baggish JS, Bhatt DL, et al. Analysis of risk of bleeding complications after different doses of aspirin in 192, 036 patients enrolled in 31 randomized controlled trials. Am J Cardiol. 2005; 95: 1218-22
81. Laine L, McQuaid K. Bleeding complications related to aspirin dose. Am J Cardiol. 2005; 96: 1035-6
82. Fisher M, Knappertz V. Comments in response to Analysis of risk of bleeding complications after different doses of aspirin in 192, 036 patients enrolled in 31 randomized controlled trials . Am J Cardiol. 2005; 96: 1467
83. Thurston AV, Briant SL. Aspirin and post-prostatectomy haemorrhage. Br J Urol. 1993; 71: 574-6
84. Nielsen JD, Holm-Nielsen A, Jespersen J, Vinther CC, Settgast IW, Gram J. The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy-A prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol. 2000; 34: 194-8
85. Korinth MC. Low-dose aspirin before intracranial surgeryresults of a survey among neurosurgeons in Germany. Acta Neurochir (Wien) 2006; 148: 1189-96
86. Stage J, Jensen JH, Bonding P. Post-Tonsillectomy haemorrhage and analgesics A comparative study of acetylsalicylic acid and paracetamol. Clin Otolaryngol. 1988; 13: 201-4
87. Oprea AD, Popescu WM. Perioperative management of antiplatelet therapy. Br J Anaesth. 2013; 111(Suppl 2): i3-i17
88. Antolovic D, Rakow A, Contin P, Ulrich A, Rahbari NN, Büchler MW, et al A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery-The APAP trial (ISRCTN45810007). Langenbeck s Arch Surg. 2012; 397: 297-306
89. Mantz J, Samama CM, Tubach F, Devereaux PJ, Collet J, Albaladejo P, et al. Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth. 2011; 107: 899-910
90. Manning BJ, O Brien N, Aravindan S, Cahill RA, McGreal G, Redmond HP. The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures. Injury. 2004; 35: 121-4
91. Sun JCJ, Whitlock R, Cheng J, Eikelboom JW, Thabane L, Crowther MA, et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. Eur Heart J. 2008; 29: 1057-71
92. Hijazi E. Aspirin does not increase bleeding and allogeneic blood transfusion in coronary artery surgery. Thorac Cardiovasc Surg. 2011; 59: 421-424
93. Franchi F, Rollini F, Angiolillo DJ. Perspectives on the management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Curr Opin Cardiol. 2014; 29: 553-63
94. Llau JV, Lopez-Forte C, Sapena L, Ferrandis R. Perioperative management of antiplatelet agents in noncardiac surgery. Eur J Anaesthesiol. 2009; 26: 181-7
95. Hyderally HA. Epidural hematoma unrelated to combined spinal-epidural anesthesia in a patient with ankylosing spondylitis receiving aspirin after total hip replacement. Anesth Analg. 2005; 100: 882
96. Gilbert A, Owens BD, Mulroy MF. Epidural hematoma after outpatient epidural anesthesia. Anesth Analg. 2002; 94: 77
97. Benzon HT, Wong HY, Siddiqui T, Ondra S. Caution in performing epidural injections in patients on several antiplatelet drugs. Anesthesiology. 1999; 91: 1558-9
98. Gerancher JC, Waterer R, Middleton J. Transient paraparesis after postdural puncture spinal hematoma in a patient receiving ketorolac. Anesthesiology. 1997; 86: 490-4
99. Williams KN, Jackowski A, Evans PJ. Epidural haematoma requiring surgical decompression following repeated cervical epidural steroid injections for chronic pain. Pain. 1990; 42: 197-9
100. Eastwood DW. Hematoma after epidural anesthesia: relationship of skin and spinal angiomas. Anesth Analg. 1991; 73: 352-4
101. Greensite FS, Katz J. Spinal subdural hematoma associated with attempted epidural anesthesia and subsequent continuous spinal anesthesia. Anesth Analg. 1980; 59: 72-3
102. Horlocker TT, Wedel DJ, Offord KP. Does preoperative antiplatelet therapy increase the risk of hemorrhagic complications associated with regional anesthesia? Anesth Analg. 1990; 70: 631-4
103. Horlocker TT, Wedel DJ, Schroeder DR, Rose SH, Elliott BA, McGregor DG, et al. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg. 1995; 80: 303-9
104. Pulmonary Embolism Prevention Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000; 355: 1295-1302
105. Horlocker TT, Bajwa ZH, Ashraf Z, Khan S, Wilson JL, Sami N, et al. Risk assessment of hemorrhagic complications associated with nonsteroidal antiinflammatory medications in ambulatory pain clinic patients undergoing epidural steroid injection. Anesth Analg. 2002; 95: 1691
106. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet. 1994; 343: 619-29
107. Sibai BM, Caritis SN, Thom E, Shaw K, McNellis D. Low-dose aspirin in nulliparous women: safety of continuous epidural block and correlation between bleeding time andmaternalneonatal bleeding complications. National Institute of Child Health and Human DevelopmentalMaternal-Fetal Medicine Network. Obstet Gynecol. 1995; 172: 1553-7
108. Urmey WF, Rowlingson J. Do antiplatelet agents contribute to the development of perioperative spinal hematoma? Reg Anesth Pain Med. 1998; 23: 146-51
109. Ruff RL, Dougherty JH Jr. Complications of lumbar puncture followed by anticoagulation. Stroke. 1981; 12: 879-81
110. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the Second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Regional Anesth Pain Med. 2003; 28: 172-97
111. Llau Pitarch JV, De Andrés Ibáñez J, Gomar Sancho C, Gómez Luque A, Hidalgo Martínez F, Torres Morera LM. Locoregional anesthesia and drugs that affect hemostasis. Suggestions of the expert meeting in the ESRA Congress in Barcelona. Rev Esp Anestesiol Reanim. 2002; 49: 468-73
112. Llau JV, De Andrés J, Gomar C, Gómez A, Hidalgo F, Torres LM. Guía clínica de fármacos inhibidores de la hemostasia y anestesia regional neuroaxial. Rev Esp Anestesiol Reanim. 2005; 52: 413-20
113. Ferrandis R.Actualizaciónde los tiempos de seguridad enanestesia regional. Rev Esp Anestesiol Reanim. 2010; 57(Suppl 1): S10-S14
114. GogartenW, Buerkle H, Van Aken H. The use of concomitant antiplatelet drugs during neuraxial anesthesia is contraindicated in Germany. Reg Anesth Pain Med. 2003; 28: 585-6
115. Vandermeulen E, Singelyn F, Vercauteren M, Brichant JF, Ickx BE, Gautier P. Belgian guidelines concerning central neural blockade in patients with drug-induced alteration of coagulation: an update. Acta Anaesthesiol Belg. 2005; 56: 139-46
116. Butwick AJ, Carvalho B. Anticoagulant and antithrombotic drugs in pregnancy: what are the anesthetic implications for labor and cesarean delivery? J Perinatol. 2011; 31: 73-84
117. Korte W, Cattaneo M, Chassot P, Eichinger S, von Heymann C, Hofmann N, et al. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost. 2011; 105: 743-9
118. Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, Hert SD, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014; 35: 2383-431
119. Ferraris VA, Saha SP, Oestreich JH, Song HK, Rosengart T, Reece TB, et al. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg. 2012; 94: 1761-81
120. Darvish-Kazem S, Gandhi M, Marcucci M, Douketis JD. Perioperative management of antiplatelet therapy in patients with a coronary stent who need noncardiac surgery: a systematic review of clinical practice guidelines. Chest. 2013; 144: 1848-56
121. Rossini R, Musumeci G, Visconti LO, Bramucci E, Castiglioni B, De Servi S, et al. Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document fromItalian cardiological, surgical and anaesthesiological societies. EuroIntervention. 2014; 10: 38-46
122. American Society of Anesthesiologists Committee on Standards and Practice Parameters. Practice alert for the perioperative management of patients with coronary artery stents: a report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology. 2009; 110: 22-3
123. Grines CL, Bonow RO, Casey DJ, Gardner TJ, Lockhart PB, Moliterno DJ, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol. 2007; 49: 734-9
124. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 64: e77-e137
125. Chassot PG, Marcucci C, Delabays A, Spahn DR. Perioperative antiplatelet therapy. Am Fam Physician. 2010; 82: 1484-9
126. Abualsaud AO, Eisenberg MJ. Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv. 2010; 3: 131-42
127. Borg T, Modig J. Potential anti-Thrombotic effects of local anaesthetics due to their inhibition of platelet aggregation. Acta Anaesthesiol Scand. 1985; 29: 739-42
128. Henny CP, Odoom JA, Ten CateH, Ten Cate JW, Oosterhoff RJ, Dabhoiwala NF, et al. Effects of extradural bupivacaine on the haemostatic system. Br J Anaesth. 1986; 58: 301-5
129. Odoom JA, Dokter PW, Sturk A, Ten Cate JW, Sih IL, Bovill JG. The influence of epidural analgesia on platelet function and correlation with plasma bupivacaine concentrations. Eur J Anaesthesiol. 1988; 5: 305-12
130. Hollmann MW, Wieczorek KS, Smart M, Durieux ME. Epidural anesthesia prevents hypercoagulation in patients undergoing major orthopedic surgery. Reg Anesth Pain Med. 2001; 26: 215-22
131. Hahnenkamp K, Theilmeier G, Van Aken HK, Hoenemann CW. The effects of local anesthetics on perioperative coagulation, inflammation, and microcirculation. Anesth Analg. 2002; 94: 1441-7
132. Spiess BD. Platelet transfusions: the science behind safety, risks and appropriate applications. Best Pract Res Clin Anaesthesiol. 2010; 24: 65-83
133. Flordal PA, Sahlin S. Use of desmopressin to prevent bleeding complications in patients treated with aspirin. Br J Surg. 1993; 80: 723-4
134. Gratz I, Koehler J, Olsen D, Afshar M, DeCastroN, Spagna PM, et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. J Thorac Cardiovasc Surg. 1992; 104: 1417-22
135. Flordal PA. Use of desmopressin to prevent bleeding in surgery. Eur J Surg. 1998; 164: 5-11
136. Crescenzi G, Landoni G, Biondi-Zoccai G, Pappalardo F, Nuzzi M, Bignami E, et al. Desmopressin reduces transfusion needs after surgery: a meta-Analysis of randomized clinical trials. Anesthesiology. 2008; 109: 1063-76
137. Altman R, Scazziota A, DE LH, Gonzalez C. Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation. J Thromb Haemost. 2006; 4: 2022-7
138. Levi M. Emergency reversal of antithrombotic treatment. Intern Emerg Med. 2009; 4: 137-45